About

Charlie Schumacher, Vice-President, Global Innovation and Development UK, at Phillips Medisize, is responsible for the day-to-day leadership of the Phillips Medisize inhalation team, formerly Vectura, which was acquired in early 2025 to expand the capabilities of the company’s global R&D organisation.

He joined the company in 2022 to lead research and development for the North America region. Prior to Phillips Medisize, Mr Schumacher spent nearly 30 years in leadership roles within the medical device, high-tech and durable consumer product industries, successfully advancing product development, commercialisation, operations and mergers & acquisitions in global organisations including Medtronic and Honeywell.